A study published in BMCMedicine finds that greater number of chronic pain sites is associated with an increased risk of all-cause dementia and Alzheimer’s disease and may be an accessible marker to assess dementia risk at early stages.
]. Thus, it remains unclear whether the excess risk is attributable to these potential confounding factors.
Currently, there is no study exploring the associations between chronic pain in multiple sites and risk of incident dementia as well as its subtypes.
]. The UK Biobank study was approved by the North West Multi-centre Research Ethics Committee, and all participants provided electronic informed consent. The current analyses were restricted to participants without self-reported or prevalent dementia at baseline.Participants were asked at baseline whether they had experienced pain at the sites of the hip, knee, back, and neck/shoulder in the last month that interfered with their usual activities.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
BMC Series blog Why AI-nursing-care projects succeed – or don‘t
Weiterlesen »
Association Between Change in Mammographic Density and Breast Cancer RiskThis nested case-control cohort study evaluates the association between change in mammographic density in each breast over time and risk of subsequent breast cancer.
Weiterlesen »
Vivienne Westwood walking tour coming to her hometown of GlossopParticipants are asked to 'dress the part'
Weiterlesen »
Is there an association between maternal bean consumption and better nutritional outcomes?Is there an association between maternal bean consumption and better nutritional outcomes? Nutrients_MDPI beans legume chili chilli maternal pregnancy womenshealth
Weiterlesen »
Glasgow housing association appoints new boss 'to always put tenants first'A Glasgow housing association has appointed a new boss in a bid 'to always put tenants first'.
Weiterlesen »
Liraglutide treatment is associated with progression of coronary artery fibrous plaque: a prospective 1-year follow-up study in asymptomatic patients with type 2 diabetes - BMC Cardiovascular DisordersObjective The objective of this study was to assess the association between clinically indicated liraglutide treatment and coronary artery plaque progression during 1-year follow-up in asymptomatic diabetes. Methods Patients were divided into a group receiving liraglutide (Lira+) and a group not receiving liraglutide (Lira-). Coronary computed tomography angiography (CCTA) was performed to assess total atheroma volume (TAV) and subtypes of plaque volumes (dense calcium, fibrous, fibrous-fatty, and necrotic core plaque) and the plaque progression during one year follow-up. Results Fifty-five patients (27%) receiving liraglutide and 149 (73%) how did not were included. Changes in TAV during 1-year of follow-up were similar in the two groups (38 ± 180 (Lira+) vs. -1 ± 160 mm3 (Lira-), P = 0.13). A greater increase in fibrous plaque volume was seen in the Lira + vs. the Lira- group (34 ± 129 vs. -2 ± 101 mm3, P = 0.04). Changes over 1-year in the other plaque subtypes were similar in the two groups. Treatment duration of liraglutide was not associated with changes in TAV. Conclusion In patients with T2D without known prior coronary artery disease, liraglutide treatment was associated with a significant increase in coronary artery fibrous plaque volume during 1-year follow-up.
Weiterlesen »